☆ 4.7 Meeting Abstract

Aspirin alone or combined with low-molecular-weight heparin in women with unexplained recurrent miscarriage, a randomised placebo-controlled trial

HUMAN REPRODUCTION (2010)

Journal

HUMAN REPRODUCTION

Volume 25, Issue -, Pages I28-I29

Publisher

OXFORD UNIV PRESS

DOI: 10.1093/humrep/de.25.s1.18

Keywords

-

Categories

Obstetrics & Gynecology Reproductive Biology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Medicine, General & Internal

Prednisone vs Placebo and Live Birth in Patients With Recurrent Implantation Failure Undergoing In Vitro Fertilization A Randomized Clinical Trial

Yun Sun, Linlin Cui, Yao Lu, Jichun Tan, Xi Dong, Tianxiang Ni, Junhao Yan, Yichun Guan, Guimin Hao, Jia-Yin Liu, Bo Zhang, Daimin Wei, Yan Hong, Yaqiong He, Jia Qi, Bing Xu, Juanjuan Lu, Qian Zhang, Shanshan Zhao, Xiaowei Ji, Xiaofang Du, Jie Zhang, Jinyong Liu, Jing Wang, Yingqin Huang, Dongmei Huang, Yanzhi Du, Hugo Vankelecom, Heping Zhang, Zi-jiang Chen

Summary: Prednisone treatment does not improve live birth rate in patients with recurrent implantation failure compared to placebo. The use of prednisone may increase the risk of preterm delivery and biochemical pregnancy loss. These findings challenge the value of prednisone use in clinical practice for the treatment of recurrent implantation failure.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Add to Collection

Article Obstetrics & Gynecology

Findings from a multicentre, observational study on reproductive outcomes in women with unexplained recurrent pregnancy loss: the OTTILIA registry

Elvira Grandone, Giovanni L. Tiscia, Mario Mastroianno, Giovanni Larciprete, Mirjana Kovac, Eleonora Tamborini Permunian, Andrea Lojacono, Doris Barcellona, Victoria Bitsadze, Jamilya Khizroeva, Alexander Makatsarya, Rossella Cacciola, Ida Martinelli, Eugenio Bucherini, Valerio De Stefano, Corrado Lodigiani, Donatella Colaizzo, Antonio De Laurenzo, Gregory Piazza, Maurizio Margaglione

Summary: The evaluation and care offered to women after unexplained recurrent pregnancy loss or intra-uterine foetal death includes thrombophilia assessment and treatment with low-molecular weight heparin and/or low-dose aspirin. Reproductive outcomes were better in women treated with these medications, especially those with thrombophilia.

HUMAN REPRODUCTION (2021)

Add to Collection

Article Obstetrics & Gynecology

Low molecular weight heparin or LMWH plus aspirin in the treatment of unexplained recurrent miscarriage with negative antiphospholipid antibodies: A meta-analysis of randomized controlled trial

Xiaoli Yan, Dan Wang, Ping Yan, Hongyu Li

Summary: This meta-analysis compared the efficacy of LMWH and LMWH combined with aspirin for uRM. The results showed that neither intervention had a substantial influence on miscarriage rate, occurrence of pre-eclampsia, or live births. Subgroup analysis indicated that enoxaparin was not effective for women with uRM and negative aPL.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss after assisted reproductive technology treatment: a protocol for a randomised, double-blind, placebo-controlled trial

Caroline Norgaard-Pedersen, Kaspar Nielsen, Rudi Steffensen, Line Eriksen, Malene Moller Jorgensen, Ulrik Schioler Kesmodel, Ole Bjarne Christiansen

Summary: This study aims to evaluate the effect of intravenous immunoglobulin and prednisolone on reproductive outcome and the immune system in women with unexplained recurrent pregnancy loss. It is a randomized, placebo-controlled trial with 74 participants. The primary objective is to assess if immunomodulatory treatment is superior to placebo in increasing the chance of ongoing pregnancy.

BMJ OPEN (2022)

Add to Collection

Article Medicine, General & Internal

Anti-Phosphatidylserine/Prothrombin Antibodies in Healthy Women with Unexplained Recurrent Pregnancy Loss

Daniel E. Pleguezuelo, Oscar Cabrera-Marante, Magdalena Abad, Edgard Alfonso Rodriguez-Frias, Laura Naranjo, Alicia Vazquez, Olga Villar, Francisco Javier Gil-Etayo, Manuel Serrano, Alfredo Perez-Rivilla, Laura de la Fuente-bitaine, Antonio Serrano

Summary: This study showed that criteria aPL were absent in the majority of patients with recurrent early miscarriage, fetal loss, and extra-criteria recurrent pregnancy loss. However, aPS/PT antibodies were positive in a significant portion of these patients. The presence of aPS/PT antibodies posed a higher risk for recurrent pregnancy loss, but successful live births were achieved in patients who received appropriate treatment.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Review Obstetrics & Gynecology

Evaluation of the effect of low molecular weight heparin in unexplained recurrent pregnancy loss: a meta-analysis of randomized controlled trials

Guangning Wang, Ran Zhang, Chuan Li, Aiping Chen

Summary: LMWH treatment may decrease the miscarriage rate in women with a history of 3 or more miscarriages, but does not reduce the incidence of miscarriage in women with a history of 2 or more miscarriages. More randomized controlled trials are needed to provide robust and reliable results.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2022)

Add to Collection

Article Environmental Sciences

Exposure of Reproductive-Aged Women to Multiple Metals and Its Associations with Unexplained Recurrent Miscarriage

Yingying Zhang, Xi Yan, Jianhua Tan, Jifan Tan, Chunsheng Liu, Pan Yang, Yanping Xian, Qiong Wang

Summary: Exposure to heavy metals can have toxic effects on female reproduction and embryo development. This study found that calcium and selenium exposure were negatively associated with miscarriage, while lead exposure was positively associated with miscarriage. Additionally, the correlations among exposures to different metals differed slightly between the control group and the uRM group.

TOXICS (2023)

Add to Collection

Review Developmental Biology

Immunomodulation for unexplained recurrent implantation failure: where are we now?

Genevieve Genest, Shorooq Banjar, Walaa Almasri, Coralie Beauchamp, Joanne Benoit, William Buckett, Frederick Dzineku, Phil Gold, Michael H. Dahan, Wael Jamal, Isaac Jacques Kadoch, Einav Kadour-Peero, Louise Lapensee, Pierre Miron, Talya Shaulov, Camille Sylvestre, Togas Tulandi, Bruce D. Mazer, Carl A. Laskin, Neal Mahutte

Summary: Immune dysfunction can cause recurrent implantation failure. This article evaluates the immune responses during implantation and the effectiveness of immunomodulatory therapies. Recurrent implantation failure (RIF) is defined as the failure to achieve pregnancy after transferring at least 3 good-quality embryos, and its cause is unexplained in 50% of cases. Currently, there are no effective treatments for unexplained RIF. Modulating the maternal immune response during implantation is a recent strategy to improve conception rates in RIF patients, but there are no confirmed diagnostic tests for immune-mediated RIF.

REPRODUCTION (2023)

Add to Collection

Article Endocrinology & Metabolism

Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Myrthe M. van Dijk, Rosa Vissenberg, Eric Fliers, Joris A. M. van der Post, Marie-Louise P. Van der Hoorn, Sabina de Weerd, Walter K. Kuchenbecker, Annemieke Hoek, J. Marko Sikkema, Harold R. Verhoeve, Kimiko A. Broeze, Corry H. de Koning, Willem Verpoest, Ole B. Christiansen, Carolien Koks, Jan P. de Bruin, Dimitri N. M. Papatsonis, Helen Torrance, Madelon van Wely, Peter H. Bisschop, Mariette Goddijn

Summary: Levothyroxine treatment did not result in higher live birth rates in euthyroid women with recurrent pregnancy loss who were positive for TPO-Ab.

LANCET DIABETES & ENDOCRINOLOGY (2022)

Add to Collection

Article Immunology

Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage

Zhi Ma, Huixia Yang, Mirjana Kessler, Markus Sperandio, Sven Mahner, Udo Jeschke, Viktoria von Schoenfeldt

Summary: Carbohydrate Lewis antigens and related glycosyltransferases are dysregulated in the decidua of patients with unexplained recurrent miscarriage. The gene FUT3 is responsible for the synthesis of sLeA in the endometrium and affects endometrial receptivity. Targeting the aberrantly elevated sLeA may be a potential therapy for inappropriate implantation in unexplained recurrent miscarriage.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Intravenous immunoglobulin treatment in women with four or more recurrent pregnancy losses: A double-blind, randomised, placebo-controlled trial

Hideto Yamada, Masashi Deguchi, Shigeru Saito, Toshiyuki Takeshita, Mari Mitsui, Tsuyoshi Saito, Takeshi Nagamatsu, Koichi Takakuwa, Mikiya Nakatsuka, Satoshi Yoneda, Katsuko Egashira, Masahito Tachibana, Keiichi Matsubara, Ritsuo Honda, Atsushi Fukui, Kanji Tanaka, Kazuo Sengoku, Toshiaki Endo, Hiroaki Yata

Summary: This study investigated whether treatment with a high dose of intravenous immunoglobulin (IVIG) in early pregnancy can improve pregnancy outcomes in women with unexplained recurrent pregnancy loss (RPL). The results showed that IVIG treatment significantly increased the ongoing pregnancy rate and live birth rate in women with unexplained RPL, suggesting that IVIG may be an effective treatment option for this condition.

ECLINICALMEDICINE (2022)

Add to Collection

Article Obstetrics & Gynecology

Anti-Mueurollerian hormone and live birth in unexplained recurrent pregnancy loss

Sofie Bliddal, Ulla Feldt-Rasmussen, Julie Lyng Forman, Linda Maria Hilsted, Elisabeth Clare Larsen, Ole Bjarne Christiansen, Claus Henrik Nielsen, Astrid Marie Kolte, Henriette Svarre Nielsen

Summary: This study examined the association between anti-Mueurollerian hormone (AMH) and live birth rate (LBR) in women with unexplained recurrent pregnancy loss (RPL). The results showed that AMH concentration was not associated with live birth in the next pregnancy. These findings suggest that screening for AMH in all women with RPL is not currently supported by evidence.

REPRODUCTIVE BIOMEDICINE ONLINE (2023)

Add to Collection

Review Endocrinology & Metabolism

Relationship Among Traditional Semen Parameters, Sperm DNA Fragmentation, and Unexplained Recurrent Miscarriage: A Systematic Review and Meta-Analysis

Yanpeng Dai, Junjie Liu, Enwu Yuan, Yushan Li, Ying Shi, Linlin Zhang

Summary: This meta-analysis explores the relationship among traditional semen parameters, SDF, and unexplained RM. The results show that couples with unexplained RM have significantly increased levels of SDF and significantly decreased levels of total motility and progressive motility. Therefore, SDF assay may be important in the evaluation of couples with unexplained RM.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Article Obstetrics & Gynecology

Whole exome sequencing in unexplained recurrent miscarriage families identified novel pathogenic genetic causes of euploid miscarriage

Xiyao Wang, Wenqiang Shi, Shaotong Zhao, Deshun Gong, Shuo Li, Cuiping Hu, Zi-Jiang Chen, Yan Li, Junhao Yan

Summary: This study utilized whole exome sequencing (WES) followed by trio bioinformatics analysis to identify genetic variants in six candidate genes that may be responsible for first trimester euploid miscarriage.

HUMAN REPRODUCTION (2023)

Add to Collection

Article Biochemistry & Molecular Biology

TMT-Based Proteomic Analysis of Human Spermatozoa from Unexplained Recurrent Miscarriage Patients before and after Oral Antioxidant Treatment

Alba Fernandez-Encinas, Jordi Ribas-Maynou, Agustin Garcia-Peiro, Sergio Garcia-Segura, Olga Martinez-Pasarell, Joaquima Navarro, Maria Oliver-Bonet, Jordi Benet

Summary: This study analyzed the effects of antioxidants on sperm proteomic profiles in recurrent miscarriage patients. The results showed that the proteomic profiles before and after antioxidant treatment were similar, but some proteins shifted towards a profile typical of fertile donors after treatment. These findings suggest that antioxidants may improve the expression of certain proteins involved in sperm DNA remodeling.

BIOMEDICINES (2022)

Add to Collection

Article Obstetrics & Gynecology

Pregnancy outcomes in women with Budd-Chiari syndrome or portal vein thrombosis - a multicentre retrospective cohort study

H. M. G. Wiegers, E. N. Hamulyak, S. E. Damhuis, J. R. van Duuren, S. Darwish Murad, L. J. J. Scheres, S. J. Gordijn, J. Leentjens, J. J. Duvekot, M. N. Lauw, B. A. Hutten, S. Middeldorp, W. Ganzevoort

Summary: Women previously diagnosed with Budd-Chiari syndrome and/or portal vein thrombosis, with or without concomitant portal hypertension, can achieve relatively good pregnancy outcomes, with a high rate of term live births and lower risk of maternal and neonatal complications. Therefore, these conditions should not be considered as absolute contraindications for pregnancy, and individualized counseling and multidisciplinary pregnancy surveillance are essential.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Add to Collection

Review Nutrition & Dietetics

Hyperemesis gravidarum and vitamin K deficiency: a systematic review

Kelly Nijsten, Lois van der Minnen, Hanke M. G. Wiegers, Marjette H. Koot, Saskia Middeldorp, Tessa J. Roseboom, Iris J. Grooten, Rebecca C. Painter

Summary: Hyperemesis gravidarum (HG), a severe condition of nausea and vomiting in pregnancy, can lead to vitamin K deficiency and related complications such as coagulopathy-related hemorrhage in mothers and intracranial hemorrhage and embryopathy in neonates. Treatment involves vitamin K supplementation in 30-50% of diagnosed cases. Incidence rates remain uncertain based on current evidence.

BRITISH JOURNAL OF NUTRITION (2022)

Add to Collection

Article Clinical Neurology

Declining mortality of cerebral venous sinus thrombosis with thrombocytopenia after SARS-CoV-2 vaccination

Anita van de Munckhof, Katarzyna Krzywicka, Diana Aguiar de Sousa, Mayte Sanchez van Kammen, Mirjam R. Heldner, Katarina Jood, Erik Lindgren, Turgut Tatlisumak, Jukka Putaala, Johanna A. Kremer Hovinga, Saskia Middeldorp, Marcel Levi, Marcel Arnold, Jose M. Ferro, Jonathan M. Coutinho

Summary: The mortality of patients with CVST-VITT after vaccination with adenoviral vector-based SARS-CoV-2 vaccines has significantly decreased over time, indicating a potential beneficial effect of early recognition and improved treatment on outcome after VITT.

EUROPEAN JOURNAL OF NEUROLOGY (2022)

Add to Collection

Article Hematology

Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis

Stephan Hendriks, Wilbert B. van den Hout, Thomas van Bemmel, Ingrid M. Bistervels, Michiel Eijsvogel, Laura M. Faber, Herman M. A. Hofstee, Tom van der Hulle, Antonio Iglesias del Sol, Marieke J. H. A. Kruip, Albert T. A. Mairuhu, Saskia Middeldorp, Mathilde Nijkeuter, Menno Huisman, Frederikus A. Klok

Summary: The study found that home treatment of hemodynamically stable patients with acute PE was associated with an estimated net cost reduction of Euro1,483 per patient, highlighting the advantage of triage-based home treatment for these patients.

THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function

Lucia Mazzolai, Walter Ageno, Adriano Alatri, Rupert Bauersachs, Cecilia Becattini, Marianne Brodmann, Joseph Emmerich, Stavros Konstantinides, Guy Meyer, Saskia Middeldorp, Manuel Monreal, Marc Righini, Victor Aboyans

Summary: This consensus document provides clinicians with updated information on the management of deep vein thrombosis, including indications for extended anticoagulation, management of cancer patients, and prevention and management of post-thrombotic syndrome. It also highlights the benefits and safety data of new non-vitamin K antagonists oral anticoagulants, as well as the arrival of new antidotes for severe bleeding management.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Women's representation in venous thromboembolism randomized trials and registries: The illustrative example of direct oral anticoagulants for acute treatment

Behnood Bikdeli, Candrika D. D. Khairani, Briana M. M. Barns, Rachel P. P. Rosovsky, David Jimenez, Manuel Monreal, Katelyn W. W. Sylvester, Saskia Middeldorp, Shannon M. M. Bates, Harlan M. M. Krumholz, Samuel Z. Z. Goldhaber, Beverley J. J. Hunt, Gregory Piazza

CONTEMPORARY CLINICAL TRIALS (2022)

Add to Collection

Article Hematology

Splanchnic vein thrombosis-related mortality in the Veneto region (Italy), 2008-2019: Retrospective analysis of epidemiological data

Giacomo Turatti, Ugo Fedeli, Luca Valerio, Frederikus A. Klok, Alexander T. Cohen, Beverley J. Hunt, Paolo Simioni, Saskia Middeldorp, Walter Ageno, Nils Kucher, Stavros Konstantinides, Elena Schievano, Stefano Barco

Summary: A study in the Veneto region of Italy from 2008 to 2019 found that the mortality rate related to splanchnic vein thrombosis (SVT) showed different trends, with an average annual increase of 5.7% in women and a decrease of 1.2% in men. Concurrent liver disease and gastrointestinal cancers are associated with SVT-related death to some extent.

THROMBOSIS RESEARCH (2022)

Add to Collection

Article Medicine, Research & Experimental

Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial

S. Immenga, R. Lodewijkx, Y. B. W. E. M. Roos, S. Middeldorp, C. B. L. M. Majoie, H. C. Willems, W. P. Vandertop, D. Verbaan

Summary: This is a randomized trial investigating the efficacy of tranexamic acid (TXA) in preventing surgery for chronic subdural hematoma (cSDH). The study includes patients using anticoagulants and mentally incompetent patients, which is significant for the target population. The final results of this study are expected to be published in 2024.

TRIALS (2022)

Add to Collection

Article Medicine, General & Internal

Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19 A Randomized Clinical Trial

Charlotte A. Bradbury, Patrick R. Lawler, Simon J. Stanworth, Bryan J. McVerry, Zoe McQuilten, Alisa M. Higgins, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Lindsay R. Berry, Elizabeth Lorenzi, Ryan Zarychanski, Yaseen M. Arabi, Djillali Annane, Abi Beane, Wilma Van Bentum-Puijk, Zahra Bhimani, Shailesh Bihari, Marc J. M. Bonten, Frank M. Brunkhorst, Adrian Buzgau, Meredith Buxton, Marc Carrier, Allen C. Cheng, Matthew Cove, Michelle A. Detry, Lise J. Estcourt, Mark Fitzgerald, Timothy D. Girard, Ewan C. Goligher, Herman Goossens, Rashan Haniffa, Thomas Hills, David T. Huang, Christopher M. Horvat, Beverley J. Hunt, Nao Ichihara, Francois Lamontagne, Helen L. Leavis, Kelsey M. Linstrum, Edward Litton, John C. Marshall, Daniel F. McAuley, Anna McGlothlin, Shay P. McGuinness, Saskia Middeldorp, Stephanie K. Montgomery, Susan C. Morpeth, Srinivas Murthy, Matthew D. Neal, Alistair D. Nichol, Rachael L. Parke, Jane C. Parker, Luis Reyes, Hiroki Saito, Marlene S. Santos, Christina T. Saunders, Ary Serpa-Neto, Christopher W. Seymour, Manu Shankar-Hari, Vanessa Singh, Timo Tolppa, Alexis F. Turgeon, Anne M. Turner, Frank L. van de Veerdonk, Cameron Green, Roger J. Lewis, Derek C. Angus, Colin J. McArthur, Scott Berry, Lennie P. G. Derde, Steve A. Webb, Anthony C. Gordon

Summary: The study results showed that among critically ill patients with COVID-19, treatment with an antiplatelet agent compared with no antiplatelet agent did not significantly improve the number of organ support-free days within 21 days. The use of antiplatelet therapy in critically ill patients with COVID-19 did not show significant benefits.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Hematology

Effect of polypharmacy on bleeding with rivaroxaban versus vitamin K antagonist for treatment of venous thromboembolism

Ingrid M. Bistervels, Roisin Bavalia, Martin Gebel, Anthonie W. A. Lensing, Saskia Middeldorp, Martin H. Prins, Michiel Coppens

Summary: Polypharmacy, including use of CYP3A4 and P-gp inhibitors, is common in venous thromboembolism (VTE) patients and is associated with increased bleeding. However, fixed-dose rivaroxaban is not associated with increased bleeding risk compared to enoxaparin/VKA in patients receiving polypharmacy and CYP3A4 and/or P-gp inhibitors. The increased bleeding risks observed with polypharmacy and use of CYP3A4 and/or P-gp inhibitors are likely explained by comorbidities and frailty, rather than pharmacokinetic interactions.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Hematology

Post-thrombotic syndrome after upper extremity deep vein thrombosis: An international Delphi consensus study

Robert J. C. M. F. de Kleijn, Ludo Schropp, Eline S. van Hattum, Cagdas Unlu, Saskia Middeldorp, Mathilde Nijkeuter, Jan Westerink, Bart-Jeroen Petri, Gert J. de Borst

Summary: This study aimed to determine a clinical score for diagnosing UE-PTS through an international Delphi consensus study. The results will facilitate future research applications.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)

Add to Collection

Article Respiratory System

Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial

Inge A. H. van den Berk, Maadrika M. N. P. Kanglie, Tjitske S. R. van Engelen, Josje Altenburg, Jouke T. Annema, Ludo F. M. Beenen, Bart Boerrigter, Marije K. Bomers, Paul Bresser, Elvin Eryigit, Maarten Groenink, Suzanne M. R. Hochheimer, Frits Holleman, Jos A. J. Kooter, Ramon B. van Loon, Mitran Keijzers, Ivo van der Lee, Paul Luijendijk, Lilian J. Meijboom, Saskia Middeldorp, Laura J. Schijf, Robin Soetekouw, Ralf W. Sprengers, Alexander D. Montauban van Swijndregt, Wouter de Monye, Milan L. Ridderikhof, Michiel M. Winter, Shandra Bipat, Marcel G. W. Dijkgraaf, Patrick M. M. Bossuyt, Jan M. Prins, Jaap Stoker

Summary: Replacing chest X-ray with ultra-low-dose chest CT (ULDCT) in the diagnostic work-up of patients suspected of non-traumatic pulmonary disease at the emergency department has similar effects on short-term functional health, hospital admissions, and length of stay. However, more incidental findings were found in the ULDCT group.

THORAX (2023)

Add to Collection

Editorial Material Critical Care Medicine

Thromboprophylaxis in critical care

Julie Helms, Saskia Middeldorp, Alex C. Spyropoulos

INTENSIVE CARE MEDICINE (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors

Jr Tuman J. Milling, Saskia Middeldorp, Lizhen Xu, Bruce Koch, Andrew Demchuk, John W. Eikelboom, Peter Verhamme, Alexander T. Cohen, Jan Beyer-Westendorf, C. Michael Gibson, Jose Lopez-Sendon, Mark Crowther, Ashkan Shoamanesh, Michiel Coppens, Jeannot Schmidt, Pierre Albaladejo, Stuart J. Connolly

Summary: This study evaluated the safety and efficacy of andexanet alfa in patients with major bleeding caused by factor Xa inhibitors. The results showed that the drug reduced anti-FXa activity and achieved good or excellent hemostatic efficacy in 80% of the patients.

CIRCULATION (2023)

Add to Collection

Review Hematology

Targeting thromboinflammation in antiphospholipid syndrome

Dorien M. Salet, Siroon Bekkering, Saskia Middeldorp, Lucas L. van den Hoogen

Summary: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the presence of antiphospholipid antibodies (aPL) that cause thrombotic and obstetric complications. APS serves as a model for studying the mechanisms of thromboinflammation and the relationship between innate immune cells and thrombosis. Monocytes are activated by aPL to produce proinflammatory cytokines and tissue factor, while neutrophils generate neutrophil extracellular traps and interact with endothelial cells, leading to thrombosis. Platelets become procoagulant upon activation by aPL and increase interactions with leukocytes. Understanding these mechanisms provides potential therapeutic targets for APS and other thromboinflammatory diseases.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.